ReWalk Robotics (NASDAQ:LFWD) Earns “Buy” Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of ReWalk Robotics (NASDAQ:LFWD) in a research report released on Monday, Benzinga reports. HC Wainwright currently has a $9.00 target price on the stock. HC Wainwright also issued estimates for ReWalk Robotics’ FY2028 earnings at $3.15 EPS.

ReWalk Robotics Price Performance

ReWalk Robotics stock opened at $5.00 on Monday. The company has a 50 day moving average price of $5.57. ReWalk Robotics has a 1-year low of $3.90 and a 1-year high of $9.10.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.91) by $0.56. ReWalk Robotics had a negative return on equity of 28.19% and a negative net margin of 159.76%. The company had revenue of $6.88 million during the quarter, compared to analyst estimates of $7.20 million. As a group, equities analysts forecast that ReWalk Robotics will post -1.82 earnings per share for the current fiscal year.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.